Not logged in
Share
Save
Share
Save
Share
SaveFirst-line nanoparticle polymeric micellar paclitaxel with gemcitabine in metastatic pancreatic cancer: a single-arm, prospective, and exploratory study
Lyu, Nan; Wang, Qianqian; Jiang, Kuirong; Xu, Dong; Wu, Yang; Zhang, Kai; Wei, Jishu; Chen, Jianmin; Guo, Feng; Lu, Zipeng; Xiao, Bin; Chen, Guosheng; Wu, Junli; Gao, Wentao; Wang, Yuqi; Wang, Fufeng; Tu, Min
Share
Save
Share
Save
Share
Save
Share
Save
Share
SaveHigh-grade uterine endometrial stromal sarcoma harboring GLI1 and MDM2/CDK4 co-amplifications
Zhang, Lili; Luan, Lijuan; Zhang, Lei; Huang, Yufeng; Gu, Wenyi; Yu, Shui; Shen, Licheng; Huang, Jie; Shao, Yang; Su, Jieakesu; Hou, Yingyong; Xu, Chen
Share
SaveEvaluation of gefitinib alone or combined with bevacizumab in patients with EGFR L858R-positive advanced non-squamous non-small cell lung cancer: an open-label, randomized, phase 2 trial (BEVA-FLFX-001) with exploratory analysis of plasma biomarkers
Zhao, Xinmin; Wu, Xianghua; Wang, Huijie; Yu, Hui; Sun, Si; Hu, Zhihuang; Lin, Ying; Zhang, Yao; Yu, Bo; Wu, Zhenhua; Xiong, Kangli; Liu, Cuicui; Wang, Song; Bao, Hua; Ou, Qiuxiang; Wang, Jialei
Share
Save
Share
SaveEstablishment and Evaluation of Prognostic Prediction Model for Diffuse Large B-Cell Lymphoma Patients Based on International Prognostic Index and FAT4, TP53 Mutation
Shao, Letian; Kou, Zhen; Abulaiti, Renaguli; Shi, Qiping; Qi, Xiaolong; Wang, Zengsheng; Zhai, Shunsheng; An, Li; Huang, Qin; Wufuer, Guzailinuer; Li, Yan
Share
SaveEvaluating sensitivity of NGS-based mutation detection across diverse sample types in prostate cancer
Jiang, Kui; Dai, Zhihong; Chen, Jiaqiang; Gao, Ziping; Tong, Heyao; Liu, Hongruo; Huang, Gena; Liu, Fang; Ma, Ya; Pan, Evanki; Yin, Jiani; Yao, Lulu; Wang, Liang
Share
SaveMRDadaptis: self-adaptive parameter configuration enhances minimal residual disease detection in heterogeneous ctDNA samples
Wang, Tianci; Lai, Xin; Wang, Shenjie; Xue, Zhengfa; Liu, Yuqian; Zhu, Xiaoyan; Wang, Xiaonan; Chang, Zhili; Shao, Yang; Zhang, Xian; Wang, Jiayin
Share
SaveTMBquant: an explainable AI-powered caller advancing tumor mutation burden quantification across heterogeneous samples
Wang, Shenjie; Wang, Xiaonan; Zhu, Xiaoyan; Wang, Xuwen; Liu, Yuqian; Zhao, Minchao; Chang, Zhili; Shao, Yang; Zhang, Haitao; Yang, Shuanying; Wang, Jiayin
Share
SaveTMBocelot: an omnibus statistical control model optimizing the TMB thresholds with systematic measurement errors
Lai, Xin; Wang, Shaoliang; Zhang, Xuanping; Zhu, Xiaoyan; Liu, Yuqian; Chang, Zhili; Wang, Xiaonan; Shao, Yang; Wang, Jiayin; Wang, Yixuan
Share
SaveGenetic feature diversity of KRAS-mutated colorectal cancer and the negative association of DNA mismatch repair deficiency relevant mutational signatures with prognosis
Shi, Ruichuan; Cheng, Yu; Wang, Jin; Song, Na; Chen, Ying; Teng, Zan; Xu, Ling; Liu, Yunpeng; Zhao, Xiaotian; Ou, Qiuxiang; Yang, Peng; Ma, Rui; Sun, Yiting; Qu, Jinglei; Qu, Xiujuan
Share
SaveComprehensive genomic and spatial immune infiltration analysis of survival outliers in extensive-stage small cell lung cancer receiving first-line chemoimmunotherapy
Jiang, Yuxin; Xie, Jingyuan; Cheng, Qinpei; Cai, Zijing; Xu, Ke; Lu, Wanjun; Wang, Fufeng; Wu, Xiaoying; Song, Yong; Lv, Tangfeng; Zhan, Ping
Share
SaveThe clinical utility of plasma circulating tumor DNA in the diagnosis and disease surveillance in non-diffuse large B-cell non-Hodgkin lymphomas
Zhang, Xiaoping; Yang, Li; Zhu, Minyi; Zhao, Xiaotian; Xiao, Yao; Pang, Jiaohui; Zhu, Liuqing; Ou, Qiuxiang; Ni, Hai-Wen; Xu, Jingyan
Share
SaveEarly postoperative plasma circulating tumour DNA for molecular residue disease detection and recurrence risk evaluation in surgical non-small cell lung cancer
Tang, Jie; Tian, Yingsong; Wang, Song; Liu, Yong; Chen, Manjun; Yang, Xudong; Tong, Xinghe; Wang, Mengtian; Zhao, Yunping; Pang, Jiaohui; Ou, Qiuxiang; Chen, Xiaobo
Share
Save